Drooid Logo
Back to today’s briefing

Story perspectives

Obesity Meds: Weight Loss Gains and Serious Risks

8/5/2025

47 5

1 of 1

Story summary
  • Patients relying on obesity medications like Wegovy and Mounjaro face the challenge of sustaining weight loss, with many experiencing regain post-treatment. The NHS emphasizes the necessity of lasting behavioral changes. Influencer Tana Mongeau raises alarms about Mounjaro's serious side effects, underscoring the importance of careful consideration when using weight-loss drugs.